Tenon Medical, Inc. Releases The Results Of The First Post-clearance Clinical Study

Submitted by Brayden Devin | May 26, 2022, 08:06:16 | News

Tenon Medical (NASDAQ: TNON) is a public medical device company that has developed a proprietary, FDA-cleared surgical implant system designed to optimize SI-Joint fixation/fusion surgery and corresponding outcomes. The company has raised over $30M in private and public equity and completed an IPO on 4/27/2022. The current market capitalization of Tenon Medical is over $450,000,000. Kal Mentak led Tenon Medical as CEO from 2015 to 2021 and through the pre-IPO stage.

Article source: https://www.prnewswire.com/news-releases/tenon-medical-inc-releases-the-results-of-the-first-post-clearance-clinical-study-301001513.html

Tag: #Kal Mentak #Pre-IPO stage #Tenon Medical

You May Like More:

Your email address will not be published. Required fields are marked *